抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
GS967，99% | C14H7F6N3O | |||
|
|
|||||
|
Oxethazaine，≥95% | C28H41N3O3 | |||
|
|
|||||
|
3,5,5-Trimethyloxazolidine-2,4-Dione，98% | C6H9NO3 | |||
|
|
|||||
|
L-655,708，≥98%(HPLC) | C18H19N3O4 | |||
|
|
|||||
|
MDL-29951，98% | C12H9Cl2NO4 | |||
|
|
|||||
|
Pyr10，99% | C18H13F6N3O2S | |||
|
|
|||||
|
Lercanidipine hydrochloride hemihydrate，99% | C36H41N3O6 · HCl · 0.5H2O | |||
|
|
|||||
|
PF-4840154，97% | C26H38N6O2 | |||
|
|
|||||
|
SAR7334，≥97% | C21H22ClN3O | |||
|
|
|||||
|
ML218，99% | C19H26Cl2N2O | |||
|
|
|||||
|
Verinurad，96% | C20H16N2O2S | |||
|
|
|||||
|
Bamaquimast ( F 10126; L 0042)，98% | C16H21N3O3 | |||
|
|
|||||
|
GAL-021，98% | C11H22N6O | |||
|
|
|||||
|
R-(+)-Lansoprazole，98% | C16H14F3N3O2S | |||
|
|
|||||
|
rac-Vigabatrin Hydrochloride，98% | C6H12ClNO2 | |||
|
|
|||||
|
ML277，98% | C23H25N3O4S2 | |||
|
|
|||||
|
GV-58，98% | C18H26N6OS | |||
|
|
|||||
|
PEPA，98% | C16H16F2N2O4S2 | |||
|
|
|||||
